High sensitivity CRP and short-term cardiovascular risk among patients with acute myocardial infarction: A two-center study

Acta Medica Philippina

Volumn 46, Issue 3, 2012, Pages 64-68

  Tiongco II, Richard Henry Perlas ^a,c   Te, Camilo G ^a   Punzalan, Felix Eduardo R ^a   Uy, Celia Catherine C ^a   Gonda, Von Meldrick A ^b  

^a UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^b MAKATI MEDICAL CENTER   (Philippines)

^c UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

Author keywords

Coronary artery disease; Hs CRP; Myocardial infarction

Indexed keywords

EID: 84878314225     PISSN: 00016071     EISSN: 20949278     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000; 342(12):836-43.
2. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997; 336(14):973-9.
3. Tomoda H, Aoki N. Prognostic value of C-reactive protein levels within six hours after the onset of acute myocardial infarction. Am Heart J. 2000; 140(2):324-8.
4. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 1999; 340(2):115-26.
5. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of Creactive protein on human endothelial cells. Circulation, 2000; 102(18):2165-8.
6. Kushner I, Broder ML, Karp D. Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction. J Clin Invest. 1978; 61(2):235-42.
7. Pietila K, Hermens WT, Harmoinen A, et al. Comparison of peak serum C-reactive protein and hydroxybutyrate dehydrogenase levels in patients with acute myocardial infarction treated with alteplase and streptokinase. Am J Cardiol. 1997; 80(8):1075-7.
8. Pietila KO, Harmoinen AP, Jokiniitty J, Pasternack AI. Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment. Eur Heart J. 1996; 17(9):1345-9.
9. Anzai T, Yoshikawa T, Shiraki H, et al. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation. 1997; 96(3):778-84.
10. Tommasi S, Carluccio E, Bentivoglio M, et al. C-reactive protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarction. Am J Cardiol. 1999; 83(12):1595-9.